Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
CAMP on Nasdaq
Shares outstanding
52,121,500
Price per share
$3.87
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
38,247,378
Total reported value
$234,599,194
% of total 13F portfolios
0%
Share change
+8,053,354
Value change
+$51,453,984
Number of holders
39
Price from insider filings
$3.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 12% $37,908,892 6,307,636 JANUS HENDERSON GROUP PLC 31 Dec 2025
5AM Ventures VI, L.P. 12% $8,392,800 5,869,091 Andrew J. Schwab 09 Sep 2025
FMR LLC 9.5% +40% $28,968,451 +$10,440,496 4,918,243 +56% FMR LLC 31 Dec 2025
Coastlands Capital LP 10% $21,452,710 4,886,722 Coastlands Capital LP 10 Sep 2025
Polaris Management Co. VII, L.L.C. 8.4% $5,623,119 3,932,251 Amir Nashat 09 Sep 2025
Vivo Opportunity Fund Holdings, L.P. 7.4% -2.5% $23,373,365 +$1,788,900 3,856,991 +8.3% Vivo Opportunity Fund Holdings, L.P. 31 Dec 2025
Enavate Sciences GP, LLC 6% -26% $13,729,110 -$2,890,560 3,127,360 -17% Enavate Sciences GP, LLC 19 Dec 2025
Northpond Ventures II, LP 4.8% $6,714,732 2,238,244 Michael P. Rubin 30 Sep 2025
AH Bio Fund I, L.P. 4.5% $6,376,017 2,125,339 Marc L. Andreessen 30 Sep 2025
HARBOURVEST PARTNERS LLC 2.7% -60% $3,536,015 1,271,948 0% HarbourVest Partners L.P. 30 Sep 2025

As of 31 Dec 2025, 39 institutional investors reported holding 38,247,378 shares of Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP). This represents 73% of the company’s total 52,121,500 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) together control 73% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 12% 6,307,636 +36% 0.02% $38,807,475
5AM Venture Management, LLC 11% 5,869,091 0% 11% $35,977,528
FMR LLC 9.4% 4,918,243 +63% 0% $30,148,830
Vivo Capital, LLC 8.1% 4,246,568 +8.3% 1.7% $26,031,462
ENAVATE SCIENCES GP, LLC 5.8% 3,035,825 -20% 3.7% $18,609,607
Balyasny Asset Management L.P. 4.7% 2,436,900 0.03% $14,938,197
ADAGE CAPITAL PARTNERS GP, L.L.C. 4.2% 2,181,679 +11% 0.02% $13,373,692
a16z Capital Management, L.L.C. 4.1% 2,125,339 0% 0.82% $13,028,328
Trails Edge Capital Partners, LP 3.8% 1,983,986 0% 3% $12,161,834
VANGUARD GROUP INC 3.2% 1,672,960 +434% 0% $10,255,245
HarbourVest Partners LLC 2.4% 1,271,948 0% 4.5% $7,797,041
BlackRock, Inc. 0.75% 390,160 +3311% 0% $2,391,681
GEODE CAPITAL MANAGEMENT, LLC 0.65% 336,293 +457% 0% $2,062,578
EcoR1 Capital, LLC 0.62% 325,000 0.09% $1,992,250
Stonepine Capital Management, LLC 0.44% 228,894 1.1% $1,403,120
Alyeska Investment Group, L.P. 0.38% 200,000 0% 0% $1,226,000
683 Capital Management, LLC 0.24% 126,363 0.06% $774,605
TWO SIGMA INVESTMENTS, LP 0.18% 94,531 -2.9% 0% $579,475
VICTORY CAPITAL MANAGEMENT INC 0.16% 82,790 0% 0% $507,503
NORTHERN TRUST CORP 0.14% 74,509 +410% 0% $456,740
BARCLAYS PLC 0.14% 73,601 +105044% 0% $451,174
STATE STREET CORP 0.08% 39,700 +53% 0% $243,361
ExodusPoint Capital Management, LP 0.07% 34,720 0% $212,834
JANE STREET GROUP, LLC 0.05% 25,534 0% $156,523
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.05% 25,000 0% 0% $153,250

Institutional Holders of Camp4 Therapeutics Corp - Common Stock, par value $0.0001 per share (CAMP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 38,247,378 $234,599,194 +$51,453,984 $6.13 39
2025 Q3 28,210,083 $84,630,390 +$49,505,803 $3.00 28
2025 Q2 11,744,129 $17,029,220 -$3,217,598 $1.45 28
2025 Q1 12,677,488 $50,710,355 -$1,002,366 $4.00 39
2024 Q4 12,854,057 $67,096,861 +$47,332,167 $5.22 36